2013 Results

COMMENTARY

This was a particularly challenging year for the Company. Reasonable revenue growth was obtained, but trading margins came under pressure as a result of competitive market conditions and the weaker Rand. Also, the Board-led process to respond to expressions of interest for control of the Company necessitated very significant effort and resources and also required that certain other strategic growth initiatives be suspended.

SALIENT FEATURES

• Turnover increased 18% to R5,45 billion
• EBITDA increased 11% to R1,1 billion
• HEPS decreased 17% to 350,5 cents
• Acquisition of Cosme brands in India concluded at a cost of R782 million
• Shareholder approval pending for scheme of arrangement proposing a cash and shares transaction with CFR
• Departure from stated dividend policy and no final dividend proposed

FINANCIALS

• Consolidated statements of comprehensive income
• Consolidated statement of changes in equity
• Consolidated statements of financial position
• Consolidated statements of cash flows
• Notes to the consolidated financial statements

DOWNLOADS

• Results booklet [PDF - 116KB]
• Presentation [PDF - 3MB]
• Webcast